A new step in strengthening our collaboration with AstraZeneca

Grupo Sur Clinical Research has been selected to join the global Partners in Care Network for nephrology, asthma, and COPD studies.

Within this framework, we will participate early in the planning and initiation of future clinical trials developed by AstraZeneca for these conditions.

This designation recognizes our team at Instituto Médico Platense as a strategic center, highlighting the quality of our work, our extensive experience in clinical research, and our strong performance in patient recruitment for clinical studies.

We remain committed to scientific advancement and patient care.